Diagnostics & Imaging Week articles from April 2004

Diagnostics & Imaging Week archives from April 2004

Direct-access testing debate includes patient, lab interests.(CLMA/ASCP annual meeting)
April 1, 2004... ATLANTA, Georgia -- Is direct-access testing simply slick marketing, or consumer empowerment at its best? The verbal jousting continued for more than an hour on stage at the Clinical Laboratory Management Association (Wayne,...

Molecular diagnostics moving into mainstream of medicine.(CLMA/ASCP annual meeting)
April 1, 2004... ATLANTA, Georgia -- From the heady days when the stars of genomics appeared on the cover of Time magazine in 2000 announcing the "Cracking of the Code" as a result of mapping the genome, diagnostics has been carried along in that wake to the...

EU officials give approval to sale of Pharmacia Diagnostics.(Report from Europe)(Brief Article)
April 1, 2004... A Diagnostics & Imaging Week Staff Report The proposed $575 million sale of Pharmacia Diagnostics (Uppsala, Sweden) to two firms by Pfizer (New York) has gotten the go-ahead from European Union regulatory officials. An agreement by...

OraSure wins FDA clearance for rapid oral POC test for HIV.(OraSure Technologies Inc.)(point-of-care )
April 1, 2004... HIV may be winning the battle today, but the disease now has a new opponent contending against it. OraSure Technologies (Bethlehem, Pennsylvania) late last week reported FDA approval for what many are calling a breakthrough application of...

Cytyc closes Novacept buy; Danaher in $425m acquisition.(Deals roundup)(Kalt-enbach & Voight GmbH)
April 1, 2004... A Diagnostics & Imaging Week Staff Report Cytyc (Boxborough, Massachusetts) said it has closed the acquisition of Novacept (Palo Alto, California), a company that manufactures and markets the NovaSure System, an endometrial ablation device...

ChromaVision to issue shares; SpectRx in $7.3m placement.(Financings roundup)
April 1, 2004... A Diagnostics & Imaging Week Staff Report ChromaVision Medical Systems (San Juan Capistrano, California), a provider of automated cell-imaging systems and manufacturer of the ACTS digital microscope system, has entered into a securities...

Genesis Bioventures (GBI: New York) reported completing a bridge financing related to its previously announced proposed merger with Corgenix Medical (Westminster, Colorado).(Financings roundup)
April 1, 2004... Genesis Bioventures; (GBI: New York) reported, completing a bridge financing related to its previously announced proposed merger with Corgenix Medical (Westminster, Colorado). The minimum offering requirement of $2 million was exceeded, and the...

Applied Imaging receives FDA okay for ER, PR applications.(Estrogen Receptor and Progesterone Receptor )
April 1, 2004... Applied Imaging (Santa Clara, California) has received 510(k) clearance flora the FDA to market its automated applications for Estrogen Receptor (ER) and Progesterone Receptor (PR) analysis in breast cancer patients. Those applications...

FDA classifies bioMerieux recall of Vitek card as Class I action.(Brief Article)
April 1, 2004... A Diagnostics & Imaging Week Staff Report Diagnostics firm bioMerieux (Durham, North Carolina) has recalled its Vitek GPS-107 Gram positive susceptibility card (lot M58X), with the FDA saying that it has concluded that the defect requiring...

Lab tests, ongoing monitoring are keys to bioterror detection.(CLMA/ASCP annual meeting)
April 1, 2004... ATLANTA, Georgia -- Bioterrorism as a threat to the U.S is certainly an issue of heightened, almost extraordinary concern today, and most people assume it is a new threat. But U.S. Army Lt. Col. Bill Nauschuetz said otherwise in a...

Paradigm Medical Industries.(People in Places)(Brief Article)
April 1, 2004... John Yoon has been appointed president and chief executive officer of Paradigm Medical Industries (Salt Lake City, Utah). He replaces Jeffrey Poore, who served in those positions for the past year. Yoon joins Paradigm Medical From 3Com, where...

Study says FISH better for determining HER-2 gene status.(fluorescence in situ hybridization)
April 1, 2004... A Diagnostics & Imaging Week Staff Report Abbott Laboratories' Molecular Diagnostics business (Abbott Park, Illinois) said a study published in the March issue of the Journal of Clinical Ontology suggests that targeted therapy for women...

Cygnus.(Financings roundup)(Brief Article)
April 1, 2004... Cygnus (Redwood City, California) reported retiring all of its outstanding convertible debentures and associated warrants under an exchange agreement with the debenture holders whereby such holders exchanged their convertible debentures for an...

Orchid Biosciences.(Financings roundup)(Brief Article)
April 1, 2004... Orchid Biosciences (Princeton, New Jersey) reported that its board has authorized a 1-for-5 reverse split of the company's common stock, which took effect March 30. The reverse stock split was approved by the company's stockholders last...

Medilabs awarded $6.5m-a-year contract for New York prisons.(Grants/contracts)
April 1, 2004... Bio-Reference Laboratories (BRLI; Elmwood Park, New Jersey) reported that the New York State Department of Corrections has awarded Medilabs (Valley Cottage, New York), a BRLI clinical laboratory, its current contract to provide clinical...

Given Imaging to trade on Tel Aviv exchange.(Briefly Noted)(Brief Article)
April 1, 2004... Given Imaging (Yokneam, Israel) said that its shares were approved for listing on the Tel Aviv Stock Exchange (TASE).The listing on TASE is in addition to the listing on the Nasdaq National Market, where Given Imaging shares trade under the...

Researchers use CombiMatrix bird flu arrays.(Briefly Noted)(Brief Article)
April 1, 2004... Acacia Research (Newport Beach, California) said that Ulrich Melcher, of the department of biochemistry and molecular biology, and Dr. Alexander Lai, department of microbiology and molecular genetics at Oklahoma State University (Stillwater,...

Transfusion recipients can't be blood donors.(Report from Europe)
April 1, 2004... As an additional precautionary measure against the possible risk of transmission of variant Creutzfeldt-jakob disease (vCJD), recipients of blood transfusions in the UK are to be excluded from donating blood in the future. The action,...

Primagen in agreements for HIV testing.(Report from Europe)(Primagen Holding BV)(Farmaplus NV, Ilex Pty Ltd. and Xakaza & Partners )(Brief Article)
April 1, 2004... Primagen Holding (Amsterdam, the Netherlands), a provider of molecular diagnostic tests for infectious diseases, AIDS and cancer, reported that it has entered into distribution agreements for its Retina Rainbow products with Farmaplus NV...

Pulsion expands product line.(Report from Europe)(Pulsion Medical Systems AG)(Brief Article)
April 1, 2004... Pulsion Medical Systems AG (Munich, Germany) said it has expanded its product line with a system for the early and less-invasive diagnosis and therapy of sepsis. The CeVOX system with a disposable optical probe continuously measures oxygen...

Exagen Diagnostics.(People in Places)(Brief Article)
April 1, 2004... Exagen Diagnostics (Albuquerque, New Mexico), focused on the discovery and development of practical prognostic genomic markers for serious diseases, reported the addition of two key staff members. Peter Hraber, PhD, has joined the company as...

Communications Systems (CSI;Minneapolis, Minnesota) reported completing the acquisition of Image Systems (Minnetonka, Minnesota).(Deals roundup)(Brief Article)
April 1, 2004... * Communications Systems (CSI;Minneapolis, Minnesota) reported completing the acquisition of Image Systems (Minnetonka, Minnesota). In which Image Systems' shareholders received just over 64 cents a share, or about $3 million in total. ...

Emergent technologies (ETI; Austin, Texas) said it has licensed antibody drug discovery technology from Texas Tech University Health Sciences Center (Lubbock, Texas).(Deals roundup)(Brief Article)
April 1, 2004... Emergent technologies (ETI; Austin, Texas) said it has licensed antibody drug discovery technology from Texas Tech University Health Sciences Center (Lubbock, Texas). It described the technology as a breakthrough integrated diagnostic and...

Ciphergen Biosystems (Fremont, California) reported acquiring the remaining 30% equity stake held in its Japanese affiliate, Ciphergen Biosystems K.K., from SC BioSciences, a unit of Sumitomo (Tokyo).(Deals roundup)(Brief Article)
April 1, 2004... Ciphergen Biosystems (Fremont, California) reported acquiring the remaining 30% equity stake held in its Japanese affiliate, Ciphergen Biosystems K.K., from SC BioSciences, a unit of Sumitomo (Tokyo). Financial terms were not disclosed....

Beckman Coulter.(Product Brief)(laboratory automation workstations)(Brief Article)
April 1, 2004... Beckman Coulter (Fullerton, California) said it has introduced two new laboratory automation workstations, the Biomek 3000 and the Biomek NX. Designed for solution-focused life sciences and clinical research markets, the flexible new platforms...

Bio Trove.(Product Briefs)(Brief Article)
April 1, 2004... Bio Trove (Woburn, Massachusetts) said it presented single nucleotide polymorphism (SNP) genotyping data from a study of human genomic samples using its high-density nanoliter through-hole array chip for PCR-based genomic assays. In the pilot...

Cepheid (Sunnyvale, California) reported that its collaborative partner, Infectio Diagnostic.(Product Briefs)(Brief Article)
April 1, 2004... Cepheid (Sunnyvale, California) reported that its collaborative partner, Infectio Diagnostic (IDI: Saint Foy, Quebec), has received clearance from the FDA to market its IDI-MRSA test for detecting methicillin-resistant straphylococcus aureus...

Epoch Biosciences (Bothell, Washington) reported that a new panel of assays targeting single nucleotide polymorphisms (SNPs) identified by researchers at the National Cancer institute (NCI; Bethesda, Maryland) as having a high association with certain cancer patient populations are available and being sold directly by Epoch.(Product Briefs)(Brief Article)
April 1, 2004... Epoch Biosciences (Bothell, Washington) reported that a new panel of assays targeting single nucleotide polymorphisms (SNPs) identified by researchers at the National Cancer institute (NCI; Bethesda, Maryland) as having a high association with...

iCAD.(Product Briefs)(Brief Article)
April 1, 2004... iCAD (Nashua, New Hampshire) reported that the U.S. Patent and Trademark Office has issued the company two patents for its Fulcrum mammography film digitizer and technology. Patent No. 6,687,0251 covers an approach that allows fast and accurate...

Nellcor (Pleasanton, California) said it is launching the Nellcor OxiMax NPB-75 Handhold Capnograph/Pulse Oximeter.(Product Briefs)(Brief Article)
April 1, 2004... Nellcor (Pleasanton, California) said it is launching the Nellcor OxiMax NPB-75 Handhold Capnograph/Pulse Oximeter. The product delivers accurate Sp[O.sub.2] and end-tidal C[O.sub.2] measurement within a convenient, portable, handheld unit. The...

Pacific Northwest Research Institute (Seattle, Washington) reported that Donald Malins, PhD, and colleagues, in collaboration with Jerry Spivak, MD, of Johns Hopkins University School of Medicine (Baltimore, Maryland), have developed statistical models for identifying patients with myelodysplastic syndrome (MDS), or who have a high risk for the disease.(Product Briefs)(Brief Article)
April 1, 2004... Pacific Northwest Research Institute (Seattle, Washington) reported that Donald Malins, PhD, and colleagues, in collaboration with Jerry Spivak, MD, of Johns Hopkins University School of Medicine (Baltimore, Maryland), have developed...

Signet Laboratories.(Product Briefs)(Brief Article)
April 1, 2004... Signet Laboratories (Dedham, Massachusetts) reported that it has received Notice of Allowance in Europe for patents protecting its Sepsis and Renal Failure Assay Technology, which have previously issued in the U.S., Canada and Australia. The...

Sysmex America.(Product Briefs)(Brief Article)
April 1, 2004... Sysmex America (Mundelein, Illinois) reported that the FDA has cleared the Body Fluid application on its XE-2100 Series Automated Hematology Analyzers. Automated body fluid analysis can now be performed on cerebrospinal fluid, serous and...

Evidence-based medicine has roles for both lab, POC tests.
April 8, 2004... ATLANTA, Georgia -- Practicing medicine has traditionally been built on learning from the healthcare providers who came before those practicing at a particular time, i.e., much like people in a variety of careers learn the expertise and secrets...

Canadian physician develops rapid viral respiratory test.
April 8, 2004... A Canadian hospital has developed a new rapid testing process to obtain a same-day diagnosis of viral respiratory illness, helping emergency room and community-based physicians determine how best to manage patients. Dr. Eva Thomas,...

Abbott Laboratories closes on $1.2 billion buy of TheraSense.(Deals roundup)
April 8, 2004... Abbott Laboratories (Abbott Park, Illinois) reported completing the acquisition of TheraSense (Alameda, California) following approval on Tuesday by holders of a majority of TheraSense common stock. TheraSense stockholders will receive $27 a...

Rain forest mission to 'stretch' Kodak's remote imaging ability.
April 8, 2004... The juxtapositions are dramatic, the ironies startling. High-tech digital imaging in the jungles of the Amazon--used to fight infections diseases in native rain forest tribes of the area, resulting from the encroachment of developed countries....

Draxis in C$20M bought deal; AAI in $10M debt transaction.(Financings roundup)(Draxis Health Inc.)
April 8, 2004... Draxis Health (Mississauga, Ontario) has entered into an agreement in which a syndicate of underwriters has agreed to purchase, on a bought deal basis, 3,053,436 units of the company at a purchase price of C$6.55 per unit, for aggregate gross...

Orchid BioSciences.(Financings roundup)(Brief Article)
April 8, 2004... Orchid BioSciences (Princeton, New Jersey) said it has implemented a reverse split of its common stock at a ratio of 1-for-5. The reverse stock split was authorized by Orchid's board of directors earlier this month and was approved by...

European officials plan debate on issues of genetic testing.(Report from Europe)(Brief Article)
April 8, 2004... The European Union will seek a clear way through the maze that genetic information is now presenting for healthcare professionals in Europe. European Research Commissioner Philippe Busquin has convened a conference of European experts in...

Agendia completes Series A financing.(Report from Europe)(Brief Article)
April 8, 2004... Agendia BV (Amsterdam, the Netherlands) has closed a Series A financing round led by Gilde Investment Management, with participation from Global Life Science Ventures and AXA Private Equity Venture Funds. Agendia is a pharmacogenomics...

Steris, U.S. Army demonstrate agent inactivation technology.(Fighting back)(Edgewood Chemical Biological Center )
April 8, 2004... Steris (Mentor, Ohio) and the U.S. Army's Edgewood Chemical Biological Center (ECBC; Aberdeen Proving Ground, Maryland) reported the first demonstration of a fumigation technology effective at inactivating both chemical and biological agents....

High-tech diagnostics offer peek at cancer fight's future.(American Association of Cancer Research)
April 8, 2004... Scientists described three novel advances aimed at early detection of cancer--a critical key to controlling or curing the disease--at the 95th annual meeting of the American Association for Cancer Research (Philadelphia, Pennsylvania) last week...

Chicago-ITEC adds four new companies to its portfolio.(Grants/contracts)(Chicago Illinois Technology Enterprise Center invests in Lambda Vision, Genomics USA, Immune Cell Therapy, and DermaAegis)
April 8, 2004... The Chicago Illinois Technology Enterprise Center (Chicago-ITEC, Chicago, Illinois), part of a statewide network of entrepreneurial development centers funded by the state of Illinois' Department of Commerce and Economic Opportunity, reported...

Human Genome Sciences (Rockville, Maryland) reported a license agreement with DakoCytomation A/S (Glostrup, Denmark), under which DakoCytomation has acquired exclusive worldwide rights to develop and commercialize pharmacogenomic diagnostic tests in the field of oncology.(American Association of Cancer Research)(Brief Article)
April 8, 2004... Human Genome Sciences (Rockville, Maryland) reported a license agreement with DakoCytomation A/S (Glostrup, Denmark), under which DakoCytomation has acquired exclusive worldwide rights to develop and commercialize pharmacogenomic diagnostic...

The V Foundation for Cancer Research.(American Association of Cancer Research)(Brief Article)
April 8, 2004... Also at the meeting, an alliance to promote and reward outstanding cancer research that links basic scientists with clinicians has been established between the AACR and The V Foundation for Cancer Research (Cary, North Carolina). The V...

Olympus America relocates to Pennsylvania.(Briefly Noted)(Brief Article)
April 8, 2004... Healthcare and electronics firm Olympus America (Long Island, New York) reported that it will relocate its headquarters to the Stabler Corporate Center in Upper Saucon Township, Pennsylvania, creating 800 jobs during the next three years....

Biosite.(Financings roundup)(Biosite Diagnostics Inc.)(Brief Article)
April 8, 2004... Biosite (San Diego, California), a developer of rapid diagnostics, said that, in accordance with Nasdaq Marketplace Rule 4350, 37 non-officer employees were granted inducement stock options covering an aggregate of 61,250 shares of common...

GE medical, Amersham merge with completion of $9.5b deal.(It's now GE Healthcare)(GE Medical Systems)
April 15, 2004... General Electric (GE: Fairfield, Connecticut) said last week that it had acquired all the outstanding shares of Amersham (Little Chalfont, UK), competing its $9.5 billion acquisition of the world leader in diagnostic imaging agents and other...

UK reports progress in its efforts on coronary disease.(Report from Europe)
April 15, 2004... A Diagnostics & Imaging Week Staff Report Health Secretary John Reid said in a report issued last month that major progress has been made in the treatment of coronary heart disease in the UK. The report, Winning the War on Heart Disease,...

R2's ImageChecker for CAD lung CT scans wins FDA clearance.(R2 Technology)(computer-aided detection)(computed tomography )
April 15, 2004... R2 Technology (Sunnyvale, California), a leader in computer-aided detection (CAD) systems For medicine, reported this week that it has received an "approvable" letter from the FDA for the company's ImageChecker computed tomography (CT) lung CAC...

Actuality says Perspecta system offers 3-D as existing 'in nature'.
April 15, 2004... Actuality Systems (Burlington. Massachusests) is offering its spatial 3-D visualization System, Perspecta Medical, to researchers who, the company hopes, can develop additional applications for what it calls the "first-ever, spatial 3-D system...

GMP Wireless Medicine rolls out first Bluetooth wireless ECG.(Electrocardiographs)
April 15, 2004... Wireless is the word of the day. But while wireless phones seem attached to nearly every ear and wireless laptops are nearly as ubiquitous, wireless systems for healthcare are in relative infancy. Now, GMP Wireless Medicine, a subsidiary...

Escalon eyes Drew Scientific; applied bio to buy Xtrana IP.(Deals roundup)(Escalon Medical Corp.)(Drew Scientific Group PLC)
April 15, 2004... A Diagnostics & Imaging Week Staff Report Escalon Medical (Wayne, Pennsylvania) said it will make an exchange offer for the of Drew Scientific Group (London), a diagnostics company that specializes in analytical systems for laboratory...

Agentase reports $100,000 in funding for detection R&D work.(Grants/contracts)(Pittsburgh Biomedical Development Corporation)
April 15, 2004... A Diagnostics & Imaging Week Staff Report Agentase (Pittsburgh, Pennsylvania), a company focused on the development and implementation of biocatalysts in a range of applications, reported receiving a $100,000 pre-seed investment from the...

ChromaVision adds to patent suit against Applied Imaging.(Court report)(ChromaVision Medical Systems)(Brief Article)
April 15, 2004... A Diagnostics & Imaging Week Staff Report ChromaVision Medical Systems (San Juan Capistrano, California) said it has amended its previously filed patent litigation against Applied Imaging (Santa Clara, California) to include infringement of...

Matritech reaches BladderChek milestone.(Briefly Noted)(Brief Article)
April 15, 2004... Matritech (Newton, Massachusetts), a developer of proteomics-based diagnostic products for the early detection of cancer, said it has reached a "significant reimbursement milestone" for its NMP22 BladderChek Test. With the exception of one...

Nanogen expects to net $7.4m from its sale of 900,000 shares.(Financings roundup)(Brief Article)
April 15, 2004... A Diagnostics & Imaging Week Staff Report Nanogen (San Diego, California) said it has sold 900,000 shares of its common stock to Institutional investors at a price of $8.60 per share, for gross proceeds of about $7.7 million. After...

Synarc opens Beijing office.(Briefly Noted)(Brief Article)
April 15, 2004... Synarc (San Francisco, California), a leader in specialized medical imaging and molecular marker services for global clinical trials, reported the opening era new office in Beijing China, as the company continues to extend its services to...

Ventana discusses reagent with FDA office.(Briefly Noted)(Ventana Medical Systems )(Brief Article)
April 15, 2004... Ventana Medical Systems (Tucson, Arizona) said it has met with the FDA Office of in Vitro Diagnostic Evaluation and Safety (OIVD) to discuss the letter Ventana recently received regarding its Human Papilloma Virus (HPV) analyte specific reagent...

Tm Bioscience to trade on Toronto exchange.(Briefly Noted)(Brief Article)
April 15, 2004... Tm Bioscience (Toronto, Ontario), which calls itself "an emerging leader in DNA-based diagnostic testing," said that its common shares have been approved for listing on the Toronto Stock Exchange (TSX; also Toronto) under the symbol "TMC." ...

Motion DNA opens testing, training center.(Briefly Noted)(Brief Article)
April 15, 2004... Motion DNA (Scottsdale, Arizona), a provider of diagnostic testing for medical professionals and sports organizations, celebrated the recent opening of its newest diagnostic testing and training center in Scottsdale. With more than 5,000...

Given Imaging on Tel Aviv 25 Index.(Briefly Noted)(Brief Article)
April 15, 2004... Given Imaging (Yokneam, Israel) reported that it has been selected to be added to the Tel Aviv 25 Index (TA 25), effective May 2. The TA 25 is the Tel Aviv Stock Exchange's (TASE) most closely tracked index and includes the 25 largest...

Prionics AG (Zurich, Switzerland), a world leader in testing procedures for bovine spongiform encephalopathy (BSE), or "mad cow" disease, and Roche Diagnostics (Basel, Switzerland), a leading in vitro diagnostics company, reported that the U.S. Department of Agriculture has approved the two Prionics BSE tests, Prionics-Check Western and Prionics-Check LIA, for use in the United States' enhanced BSE surveillance program.(Product Briefs)(Brief Article)
April 15, 2004... Prionics AG (Zurich, Switzerland), a world leader in testing procedures for bovine spongiform encephalopathy (BSE), or "mad cow" disease, and Roche Diagnostics (Basel, Switzerland), a leading in vitro diagnostics company, reported that the U.S....

Abbott Laboratories.(Product Briefs)(Brief Article)
April 15, 2004... Abbott Laboratories (Abbott Park, Illinois) reported that the U.S. Department of Agriculture (USDA) has given Abbott permission to sell and distribute its bovine spongiform encephalopathy (BSE) test. The rapid Enfer BSE test provides results...

Aclara BioSciences.(Product Briefs)(Brief Article)
April 15, 2004... Aclara BioSciences (Mountain View, California) reported the issuance of four U.S. patents related to its eTag technology No. 6,682,887 and No. 6,686,152, with claims related to certain eTag applications: No. 6,673,550, with broad claims related...

Avitar (Canton, Massachusetts) said it received high marks for its ORALscreen instant test for drugs-of-abuse by the Forensic Science Laboratory at Osaka Prefectural Police Headquarters (Osaka, Japan).(Product Briefs)(Brief Article)
April 15, 2004... Avitar (Canton, Massachusetts) said it received high marks for its ORALscreen instant test for drugs-of-abuse by the Forensic Science Laboratory at Osaka Prefectural Police Headquarters (Osaka, Japan). In an article in the March Issue of the...

CardioDynamics.(Product Briefs)(CardioDynamics International Corp.)(Brief Article)
April 15, 2004... CardioDynamics (San Diego, California). reported publication of seven peer-reviewed articles in Congestive Heart Failure March/April 2004 supplement. The articles demonstrate the company's impedance Cardiography (ICG) technology's accuracy...

ChromaVision Medical Systems.(Product Briefs)(Brief Article)
April 15, 2004... ChromaVision Medical Systems (San Juan Capistrano, California) said that it has been granted an additional U.S. patent that extends the company's claims related to its ACIS digital microscope system. U.S. patent No. 6,718,053, "Method and...

Encision.(Product Briefs)(Brief Article)
April 15, 2004... Encision (Boulder, Colorado) said its AEM surgical instrument technology was highlighted during the Society of American Gastrointestinal Endoscopic Surgeons meeting earlier this month in Denver, Colorado. Dr. Yuri Casseres presented data on the...

Imgenex.(Product Briefs)(Brief Article)
April 15, 2004... Imgenex (San Diego, California) said it is offering, for research use only, a sandwich ELISA kit to quantitatively measure the presence of severe acute respiratory syndrome (SARS) nucleocapsid (SARS-N) protein in infected cells or serum....

Medical Services International.(Product Briefs)(Brief Article)
April 15, 2004... Medical Services International (Edmonton, Alberta) reported that it has started a second-stage clinical trial with its VScan tuberculosis (TB) rapid test kit. The clinical trial is being done in India, which has one of the highest incidences of...

Nellcor.(Product Briefs)(Brief Article)
April 15, 2004... Nellcor (Pleasanton, California) reported that a study presented at last December's American Association for Respiratory Care meeting found its OxlMax Max-Fast Forehead Sensor performs with better accuracy and reliability than traditional digit...

Feigal to leave position as CDRH director at month's end.(Center for Devices and Radiological Health)(David Feigal Jr.)
April 22, 2004... WASHINGTON--David Feigal Jr., MD, has announced his resignation as director of the FDA's Center for Devices and Radiological Health (CDRH), a post he has held since 1999. He will serve until the end of this month and then move to Arizona, where...

Cepheid to market GeneXpert biothreat products in Europe.(Report from Europe)(Brief Article)
April 22, 2004... The U.S. State Department has granted Cepheid (Sunnyvale, California) an export license for its GeneXpert system and GeneXpert Anthrax test cartridge, allowing the company to market the products to certain European nations for biothreat...

Study in JAMA suggests virtual colonoscopy not as accurate.(comparison of virtual colonoscopy and standard colonoscopy)
April 22, 2004... A study camper mg computed tomographic colonograpy, otherwise known as virtual colonoscopy, with standard colonoscopy, and reported in the April 14 issue of the Journal of the American Medical Association (JAMA), has suggested that results from...

Jury: MJ Research must pay $19.8M to Applied Bio, Roche.(Court report)(Applied Biosystems)(Hoffmann-La Roche Inc. Roche Molecular Systems)
April 22, 2004... Applied Biosystems (Foster City, California), an Applera Corp. (Norwalk, Connecticut) unit, reported that a U.S. District Court jury in New Haven, Connecticut, has returned a favorable decision in a lawsuit brought by Applera and Roche...

Neoprobe reports success with FDA in reinitiating RIGS effort.(Radio Image-Guided Surgery)
April 22, 2004... Medical technology company Neoprobe (Dublin, Ohio) said Monday that it is reinitiating a commitment to pursue a Biologic License Application (BLA) for FDA approval of its RIGS (Radio Image-Guided Surgery) technology, and it reported results...

Beckman Coulter in 3-year, $150m contracts with Premier.(Grants/contracts)
April 22, 2004... Beckman Coulter (Fullerton, California) has signed several new three-year agreements with Premier (San Diego, California), a group purchasing organization, effective March 31. The new contracts--which include pricing agreements for Beckman...

Philips Medical Systems (Andover, Massachusets) has signed a long-term strategic alliance with Fletcher Allen Health Care (Burlington, Vermont).(Grants/contracts)
April 22, 2004... Philips Medical Systems (Andover, Massachusets) has signed a long-term strategic alliance with Fletcher Allen Health Care (Burlington, Vermont), which in alliance with the University of Vermont College of Medicine is Vermont's only academic...

Acrongenomics agrees to buy four patents from scientist.(Deals roundup)(Dr. Leftheris Georgakopoulos)
April 22, 2004... Acrongenomics (Calgary, Alberta) said it has agreed to acquire four patents, as well as all intellectual property associated with such patents, from Dr. Leftheris Georgakopoulos, a Creek scientist. The company will issue 4 million shares of...

Acacia obtains commitments to purchase $15m in stock.(Financings roundup)(Acacia Research-CombiMatrix )
April 22, 2004... Acacia Research (Newport Beach, California) reported obtaining commitments to purchase $15 million of its Acacia Research-CombiMatrix common stock in a registered direct offering. Under the terms of the transaction, Acacia will sell 3...

Vencor expands relationship with Home Access Health.(Agreements)
April 22, 2004... Vencor International (Beverly Hills, California), a global manufacturer and distributor of molecular diagnostics technologies and in vitro point-of-care rapid diagnostic tests that identify diseases, said it is expanding its newly developed...

Pickhardt points to 'deficiencies' in JAMA study on colonoscopy.(Perry Pickhardt)
April 22, 2004... A Diagnostics & Imaging Week Staff Report In response to the Journal of the American Medical Association (JAMA) article casting doubt on the quality of virtual colonoscopy, Viatronix (Stony Brook, New York), manufacturer of the Viatronix...